カテゴリー： LP Information, 世界, 医療/バイオ

世界のモノクローナル抗体市場予測 2021年-2026年

【英語タイトル】Global Monoclonal Antibodies Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9592）・商品コード：LPI21MY9592
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2025年版があります。お問い合わせください）
・ページ数：164
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「モノクローナル抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、がん、自己免疫疾患、感染症、血液疾患、その他など、用途別には、腫瘍、自己免疫＆炎症性疾患、呼吸器疾患、眼科などにセグメント区分してまとめました。モノクローナル抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・モノクローナル抗体の世界市場概要（サマリー）
・モノクローナル抗体の企業別販売量・売上
・モノクローナル抗体の企業別市場シェア
・モノクローナル抗体の世界市場規模 2016年-2021年：種類別（がん、自己免疫疾患、感染症、血液疾患、その他）
・モノクローナル抗体の世界市場規模 2016年-2021年：用途別（腫瘍、自己免疫＆炎症性疾患、呼吸器疾患、眼科）
・モノクローナル抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・モノクローナル抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・モノクローナル抗体のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・モノクローナル抗体の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・モノクローナル抗体市場の成長要因・課題・動向
・モノクローナル抗体の世界市場予測 2021年-2026年
・モノクローナル抗体の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・モノクローナル抗体のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・モノクローナル抗体のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・モノクローナル抗体の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・モノクローナル抗体の世界市場予測：種類別（がん、自己免疫疾患、感染症、血液疾患、その他）
・モノクローナル抗体の世界市場予測：用途別（腫瘍、自己免疫＆炎症性疾患、呼吸器疾患、眼科）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Monoclonal Antibodies will have significant change from previous year. By the most conservative estimates of global Monoclonal Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Monoclonal Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monoclonal Antibodies Consumption 2016-2026
2.1.2 Monoclonal Antibodies Consumption CAGR by Region
2.2 Monoclonal Antibodies Segment by Type
2.2.1 Cancer
2.2.2 Autoimmune Diseases
2.2.3 Infection
2.2.4 Hematological Diseases
2.2.5 Others
2.3 Monoclonal Antibodies Sales by Type
2.3.1 Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)
2.3.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)
2.3.3 Global Monoclonal Antibodies Sale Price by Type (2016-2021)
2.4 Monoclonal Antibodies Segment by Application
2.4.1 Oncology
2.4.2 Autoimmune and inflammatory diseases
2.4.3 Respiratory diseases
2.4.4 Ophthalmology
2.5 Monoclonal Antibodies Sales by Application
2.5.1 Global Monoclonal Antibodies Sale Market Share by Application (2016-2021)
2.5.2 Global Monoclonal Antibodies Revenue and Market Share by Application (2016-2021)
2.5.3 Global Monoclonal Antibodies Sale Price by Application (2016-2021)

3 Global Monoclonal Antibodies by Company
3.1 Global Monoclonal Antibodies Sales Market Share by Company
3.1.1 Global Monoclonal Antibodies Sales by Company (2019-2021)
3.1.2 Global Monoclonal Antibodies Sales Market Share by Company (2019-2021)
3.2 Global Monoclonal Antibodies Revenue Market Share by Company
3.2.1 Global Monoclonal Antibodies Revenue by Company (2019-2021)
3.2.2 Global Monoclonal Antibodies Revenue Market Share by Company (2019-2021)
3.3 Global Monoclonal Antibodies Sale Price by Company
3.4 Global Manufacturers Monoclonal Antibodies Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibodies Product Location Distribution
3.4.2 Players Monoclonal Antibodies Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Monoclonal Antibodies by Region
4.1 Global Monoclonal Antibodies by Region
4.1.1 Global Monoclonal Antibodies Sales by Region
4.1.2 Global Monoclonal Antibodies Revenue by Region
4.2 Americas Monoclonal Antibodies Sales Growth
4.3 APAC Monoclonal Antibodies Sales Growth
4.4 Europe Monoclonal Antibodies Sales Growth
4.5 Middle East & Africa Monoclonal Antibodies Sales Growth

5 Americas
5.1 Americas Monoclonal Antibodies Sales by Country
5.1.1 Americas Monoclonal Antibodies Sales by Country (2016-2021)
5.1.2 Americas Monoclonal Antibodies Revenue by Country (2016-2021)
5.2 Americas Monoclonal Antibodies Sales by Type
5.3 Americas Monoclonal Antibodies Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Monoclonal Antibodies Sales by Region
6.1.1 APAC Monoclonal Antibodies Sales by Region (2016-2021)
6.1.2 APAC Monoclonal Antibodies Revenue by Region (2016-2021)
6.2 APAC Monoclonal Antibodies Sales by Type
6.3 APAC Monoclonal Antibodies Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Monoclonal Antibodies by Country
7.1.1 Europe Monoclonal Antibodies Sales by Country (2016-2021)
7.1.2 Europe Monoclonal Antibodies Revenue by Country (2016-2021)
7.2 Europe Monoclonal Antibodies Sales by Type
7.3 Europe Monoclonal Antibodies Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Monoclonal Antibodies by Country
8.1.1 Middle East & Africa Monoclonal Antibodies Sales by Country (2016-2021)
8.1.2 Middle East & Africa Monoclonal Antibodies Revenue by Country (2016-2021)
8.2 Middle East & Africa Monoclonal Antibodies Sales by Type
8.3 Middle East & Africa Monoclonal Antibodies Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Monoclonal Antibodies Distributors
10.3 Monoclonal Antibodies Customer

11 Global Monoclonal Antibodies Market Forecast
11.1 Global Monoclonal Antibodies Forecast by Region
11.1.1 Global Monoclonal Antibodies Forecast by Regions (2021-2026)
11.2.2 Global Monoclonal Antibodies Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Monoclonal Antibodies Forecast by Type
11.7 Global Monoclonal Antibodies Forecast by Application

12 Key Players Analysis
12.1 AbbVie
12.1.1 AbbVie AbbVie Company Information
12.1.2 AbbVie Monoclonal Antibodies Product Offered
12.1.3 AbbVie Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AbbVie Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Monoclonal Antibodies Product Offered
12.2.3 Roche Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Roche Main Business Overview
12.2.5 Roche Latest Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information
12.3.2 Johnson & Johnson Monoclonal Antibodies Product Offered
12.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Johnson & Johnson Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Amgen
12.4.1 Amgen Company Information
12.4.2 Amgen Monoclonal Antibodies Product Offered
12.4.3 Amgen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Amgen Main Business Overview
12.4.5 Amgen Latest Developments
12.5 Merck
12.5.1 Merck Company Information
12.5.2 Merck Monoclonal Antibodies Product Offered
12.5.3 Merck Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merck Main Business Overview
12.5.5 Merck Latest Developments
12.6 BMS
12.6.1 BMS Company Information
12.6.2 BMS Monoclonal Antibodies Product Offered
12.6.3 BMS Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 BMS Main Business Overview
12.6.5 BMS Latest Developments
12.7 Eli Lilly
12.7.1 Eli Lilly Company Information
12.7.2 Eli Lilly Monoclonal Antibodies Product Offered
12.7.3 Eli Lilly Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Eli Lilly Main Business Overview
12.7.5 Eli Lilly Latest Developments
12.8 Formation Biologics
12.8.1 Formation Biologics Company Information
12.8.2 Formation Biologics Monoclonal Antibodies Product Offered
12.8.3 Formation Biologics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Formation Biologics Main Business Overview
12.8.5 Formation Biologics Latest Developments
12.9 Genmab
12.9.1 Genmab Company Information
12.9.2 Genmab Monoclonal Antibodies Product Offered
12.9.3 Genmab Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Genmab Main Business Overview
12.9.5 Genmab Latest Developments
12.10 GlaxoSmithKline
12.10.1 GlaxoSmithKline Company Information
12.10.2 GlaxoSmithKline Monoclonal Antibodies Product Offered
12.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GlaxoSmithKline Main Business Overview
12.10.5 GlaxoSmithKline Latest Developments
12.11 Human Genome Sciences
12.11.1 Human Genome Sciences Company Information
12.11.2 Human Genome Sciences Monoclonal Antibodies Product Offered
12.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Human Genome Sciences Main Business Overview
12.11.5 Human Genome Sciences Latest Developments
12.12 mmunogen
12.12.1 mmunogen Company Information
12.12.2 mmunogen Monoclonal Antibodies Product Offered
12.12.3 mmunogen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 mmunogen Main Business Overview
12.12.5 mmunogen Latest Developments
12.13 MedImmune
12.13.1 MedImmune Company Information
12.13.2 MedImmune Monoclonal Antibodies Product Offered
12.13.3 MedImmune Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 MedImmune Main Business Overview
12.13.5 MedImmune Latest Developments
12.14 Novartis
12.14.1 Novartis Company Information
12.14.2 Novartis Monoclonal Antibodies Product Offered
12.14.3 Novartis Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Novartis Main Business Overview
12.14.5 Novartis Latest Developments
12.15 Pfizer
12.15.1 Pfizer Company Information
12.15.2 Pfizer Monoclonal Antibodies Product Offered
12.15.3 Pfizer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Pfizer Main Business Overview
12.15.5 Pfizer Latest Developments
12.16 Seattle Genetics
12.16.1 Seattle Genetics Company Information
12.16.2 Seattle Genetics Monoclonal Antibodies Product Offered
12.16.3 Seattle Genetics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Seattle Genetics Main Business Overview
12.16.5 Seattle Genetics Latest Developments
12.17 Stemcentrx
12.17.1 Stemcentrx Company Information
12.17.2 Stemcentrx Monoclonal Antibodies Product Offered
12.17.3 Stemcentrx Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Stemcentrx Main Business Overview
12.17.5 Stemcentrx Latest Developments
12.18 Synthon Biopharmaceuticals
12.18.1 Synthon Biopharmaceuticals Company Information
12.18.2 Synthon Biopharmaceuticals Monoclonal Antibodies Product Offered
12.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Synthon Biopharmaceuticals Main Business Overview
12.18.5 Synthon Biopharmaceuticals Latest Developments
12.19 Takeda
12.19.1 Takeda Company Information
12.19.2 Takeda Monoclonal Antibodies Product Offered
12.19.3 Takeda Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Takeda Main Business Overview
12.19.5 Takeda Latest Developments
12.20 Teva
12.20.1 Teva Company Information
12.20.2 Teva Monoclonal Antibodies Product Offered
12.20.3 Teva Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Teva Main Business Overview
12.20.5 Teva Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Monoclonal Antibodies Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Cancer
Table 3. Major Players of Autoimmune Diseases
Table 4. Major Players of Infection
Table 5. Major Players of Hematological Diseases
Table 6. Major Players of Others
Table 7. Global Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)
Table 8. Global Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 9. Global Monoclonal Antibodies Revenue by Type (2016-2021) & ($ million)
Table 10. Global Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Table 11. Global Monoclonal Antibodies Sale Price by Type (2016-2021)
Table 12. Global Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)
Table 13. Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 14. Global Monoclonal Antibodies Value by Application (2016-2021)
Table 15. Global Monoclonal Antibodies Revenue Market Share by Application (2016-2021)
Table 16. Global Monoclonal Antibodies Sale Price by Application (2016-2021)
Table 17. Global Monoclonal Antibodies Sales by Company (2019-2021) & (Kg)
Table 18. Global Monoclonal Antibodies Sales Market Share by Company (2019-2021)
Table 19. Global Monoclonal Antibodies Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Monoclonal Antibodies Revenue Market Share by Company (2019-2021)
Table 21. Global Monoclonal Antibodies Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Monoclonal Antibodies Producing Area Distribution and Sales Area
Table 23. Players Monoclonal Antibodies Products Offered
Table 24. Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Monoclonal Antibodies Sales by Region (2016-2021) (Kg)
Table 28. Global Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 29. Global Monoclonal Antibodies Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Table 31. Americas Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 32. Americas Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 33. Americas Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 35. Americas Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)
Table 36. Americas Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 37. Americas Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)
Table 38. Americas Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 39. APAC Monoclonal Antibodies Sales by Region (2016-2021) & (Kg)
Table 40. APAC Monoclonal Antibodies Sales Market Share by Region (2016-2021)
Table 41. APAC Monoclonal Antibodies Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
Table 43. APAC Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)
Table 44. APAC Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 45. APAC Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)
Table 46. APAC Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 47. Europe Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 48. Europe Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 49. Europe Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 51. Europe Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)
Table 52. Europe Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 53. Europe Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)
Table 54. Europe Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Monoclonal Antibodies Sales by Country (2016-2021) & (Kg)
Table 56. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Monoclonal Antibodies Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Monoclonal Antibodies Sales by Type (2016-2021) & (Kg)
Table 60. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Monoclonal Antibodies Sales by Application (2016-2021) & (Kg)
Table 62. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Table 63. Global Monoclonal Antibodies Sales Forecast by Type (2021-2026) & (Kg)
Table 64. Global Monoclonal Antibodies Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Monoclonal Antibodies Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Monoclonal Antibodies Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Monoclonal Antibodies Sales Forecast by Application (2021-2026) & (Kg)
Table 68. Global Monoclonal Antibodies Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Monoclonal Antibodies Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Monoclonal Antibodies Revenue Market Share Forecast by Application (2021-2026)
Table 71. AbbVie Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 72. AbbVie Monoclonal Antibodies Product Offered
Table 73. AbbVie Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 74. AbbVie Main Business
Table 75. AbbVie Latest Developments
Table 76. Roche Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 77. Roche Monoclonal Antibodies Product Offered
Table 78. Roche Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Johnson & Johnson Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 82. Johnson & Johnson Monoclonal Antibodies Product Offered
Table 83. Johnson & Johnson Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86. Amgen Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 87. Amgen Monoclonal Antibodies Product Offered
Table 88. Amgen Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. Merck Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Monoclonal Antibodies Product Offered
Table 93. Merck Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. BMS Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 97. BMS Monoclonal Antibodies Product Offered
Table 98. BMS Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 99. BMS Main Business
Table 100. BMS Latest Developments
Table 101. Eli Lilly Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 102. Eli Lilly Monoclonal Antibodies Product Offered
Table 103. Eli Lilly Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 104. Eli Lilly Main Business
Table 105. Eli Lilly Latest Developments
Table 106. Formation Biologics Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 107. Formation Biologics Monoclonal Antibodies Product Offered
Table 108. Formation Biologics Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 109. Formation Biologics Main Business
Table 110. Formation Biologics Latest Developments
Table 111. Genmab Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 112. Genmab Monoclonal Antibodies Product Offered
Table 113. Genmab Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 114. Genmab Main Business
Table 115. Genmab Latest Developments
Table 116. GlaxoSmithKline Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 117. GlaxoSmithKline Monoclonal Antibodies Product Offered
Table 118. GlaxoSmithKline Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 119. GlaxoSmithKline Main Business
Table 120. GlaxoSmithKline Latest Developments
Table 121. Human Genome Sciences Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 122. Human Genome Sciences Monoclonal Antibodies Product Offered
Table 123. Human Genome Sciences Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 124. Human Genome Sciences Main Business
Table 125. Human Genome Sciences Latest Developments
Table 126. mmunogen Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 127. mmunogen Monoclonal Antibodies Product Offered
Table 128. mmunogen Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 129. mmunogen Main Business
Table 130. mmunogen Latest Developments
Table 131. MedImmune Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 132. MedImmune Monoclonal Antibodies Product Offered
Table 133. MedImmune Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 134. MedImmune Main Business
Table 135. MedImmune Latest Developments
Table 136. Novartis Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 137. Novartis Monoclonal Antibodies Product Offered
Table 138. Novartis Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 139. Novartis Main Business
Table 140. Novartis Latest Developments
Table 141. Pfizer Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 142. Pfizer Monoclonal Antibodies Product Offered
Table 143. Pfizer Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 144. Pfizer Main Business
Table 145. Pfizer Latest Developments
Table 146. Seattle Genetics Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 147. Seattle Genetics Monoclonal Antibodies Product Offered
Table 148. Seattle Genetics Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 149. Seattle Genetics Main Business
Table 150. Seattle Genetics Latest Developments
Table 151. Stemcentrx Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 152. Stemcentrx Monoclonal Antibodies Product Offered
Table 153. Stemcentrx Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 154. Stemcentrx Main Business
Table 155. Stemcentrx Latest Developments
Table 156. Synthon Biopharmaceuticals Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 157. Synthon Biopharmaceuticals Monoclonal Antibodies Product Offered
Table 158. Synthon Biopharmaceuticals Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 159. Synthon Biopharmaceuticals Main Business
Table 160. Synthon Biopharmaceuticals Latest Developments
Table 161. Takeda Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 162. Takeda Monoclonal Antibodies Product Offered
Table 163. Takeda Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 164. Takeda Main Business
Table 165. Takeda Latest Developments
Table 166. Teva Basic Information, Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
Table 167. Teva Monoclonal Antibodies Product Offered
Table 168. Teva Monoclonal Antibodies Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 169. Teva Main Business
Table 170. Teva Latest Developments
List of Figures
Figure 1. Picture of Monoclonal Antibodies
Figure 2. Monoclonal Antibodies Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibodies Sales Growth Rate 2016-2026 (Kg)
Figure 7. Global Monoclonal Antibodies Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Monoclonal Antibodies Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Cancer
Figure 10. Product Picture of Autoimmune Diseases
Figure 11. Product Picture of Infection
Figure 12. Product Picture of Hematological Diseases
Figure 13. Product Picture of Others
Figure 14. Global Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 15. Global Monoclonal Antibodies Revenue Market Share by Type (2016-2021)
Figure 16. Monoclonal Antibodies Consumed in Oncology
Figure 17. Global Monoclonal Antibodies Market: Oncology (2016-2021) & (Kg)
Figure 18. Monoclonal Antibodies Consumed in Autoimmune and inflammatory diseases
Figure 19. Global Monoclonal Antibodies Market: Autoimmune and inflammatory diseases (2016-2021) & (Kg)
Figure 20. Monoclonal Antibodies Consumed in Respiratory diseases
Figure 21. Global Monoclonal Antibodies Market: Respiratory diseases (2016-2021) & (Kg)
Figure 22. Monoclonal Antibodies Consumed in Ophthalmology
Figure 23. Global Monoclonal Antibodies Market: Ophthalmology (2016-2021) & (Kg)
Figure 24. Global Monoclonal Antibodies Sales Market Share by Application (2016-2021)
Figure 25. Global Monoclonal Antibodies Revenue Market Share by Application in 2020
Figure 26. Global Monoclonal Antibodies Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Monoclonal Antibodies Revenue Market Share by Company in 2020
Figure 28. Global Monoclonal Antibodies Sales Market Share by Regions (2016-2021)
Figure 29. Global Monoclonal Antibodies Revenue Market Share by Region in 2020
Figure 30. Americas Monoclonal Antibodies Sales 2016-2021 (Kg)
Figure 31. Americas Monoclonal Antibodies Revenue 2016-2021 ($ Millions)
Figure 32. APAC Monoclonal Antibodies Sales 2016-2021 (Kg)
Figure 33. APAC Monoclonal Antibodies Revenue 2016-2021 ($ Millions)
Figure 34. Europe Monoclonal Antibodies Sales 2016-2021 (Kg)
Figure 35. Europe Monoclonal Antibodies Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Monoclonal Antibodies Sales 2016-2021 (Kg)
Figure 37. Middle East & Africa Monoclonal Antibodies Revenue 2016-2021 ($ Millions)
Figure 38. Americas Monoclonal Antibodies Sales Market Share by Country in 2020
Figure 39. Americas Monoclonal Antibodies Revenue Market Share by Country in 2020
Figure 40. Americas Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 41. Americas Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 42. United States Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Monoclonal Antibodies Sales Market Share by Region in 2020
Figure 47. APAC Monoclonal Antibodies Revenue Market Share by Regions in 2020
Figure 48. APAC Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 49. APAC Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 50. China Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Monoclonal Antibodies Sales Market Share by Country in 2020
Figure 57. Europe Monoclonal Antibodies Revenue Market Share by Country in 2020
Figure 58. Europe Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 59. Europe Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 60. Germany Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application in 2020
Figure 69. Egypt Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Monoclonal Antibodies Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles


★調査レポート[世界のモノクローナル抗体市場予測 2021年-2026年] (コード：LPI21MY9592)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のモノクローナル抗体市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の幹細胞研究製品市場予測 2021年-2026年
    LPI21MY9677 / LP Information / 2021年5月 / LPインフォメーション社の「幹細胞研究製品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。幹細胞研究製品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・幹細胞研究製品の世界市場概要（サマリー） ・幹細胞研究製品の企業別販売量・売上 ・幹細胞研究製品の企業別市場シェア ・幹細胞研究製品の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・幹細胞研究製品の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・幹細胞研究製品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・幹細胞研究製品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Trial Size Antibodies will have significant change from previous year. By the most conservative estimates of global Trial Size Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Trial Size Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Trial Size Antibodies market by product type,...
  • 世界の連鎖状球菌肺炎抗体市場予測 2021年-2026年
    LPI21MY9664 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌肺炎抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌肺炎抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌肺炎抗体の世界市場概要（サマリー） ・連鎖状球菌肺炎抗体の企業別販売量・売上 ・連鎖状球菌肺炎抗体の企業別市場シェア ・連鎖状球菌肺炎抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌肺炎抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌肺炎抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌肺炎抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Pneumoniae Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Pneumoniae Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Pneumoniae Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Antibodies market by product type,...
  • 世界の連鎖状球菌グループA抗体市場予測 2021年-2026年
    LPI21MY9662 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌グループA抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌グループA抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌グループA抗体の世界市場概要（サマリー） ・連鎖状球菌グループA抗体の企業別販売量・売上 ・連鎖状球菌グループA抗体の企業別市場シェア ・連鎖状球菌グループA抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌グループA抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌グループA抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌グループA抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Group A Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Group A Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Group A Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Group A Antibodies...
  • 世界のCD38モノクローナル抗体薬市場予測 2021年-2026年
    LPI21MY9468 / LP Information / 2021年5月 / LPインフォメーション社の「CD38モノクローナル抗体薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ダレツズマブ、イサルツキシマブ、人工毒素体など、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他などにセグメント区分してまとめました。CD38モノクローナル抗体薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・CD38モノクローナル抗体薬の世界市場概要（サマリー） ・CD38モノクローナル抗体薬の企業別販売量・売上 ・CD38モノクローナル抗体薬の企業別市場シェア ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：種類別（ダレツズマブ、イサルツキシマブ、人工毒素体） ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：用途別（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他） ・CD38モノクローナル抗体薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・CD38モノクローナル抗体薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of CD38 Monoclonal Antibody Drugs will have significant change from previous year. By the most conservative estimates of global CD38 Monoclonal Antibody Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CD38 Monoclonal Antibody Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of CD38 Monoclonal Antibody Drugs...
  • 世界のクラミジアトラコマチス抗体市場予測 2021年-2026年
    LPI21MY9479 / LP Information / 2021年5月 / LPインフォメーション社の「クラミジアトラコマチス抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオテクノロジー、研究機関、その他などにセグメント区分してまとめました。クラミジアトラコマチス抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・クラミジアトラコマチス抗体の世界市場概要（サマリー） ・クラミジアトラコマチス抗体の企業別販売量・売上 ・クラミジアトラコマチス抗体の企業別市場シェア ・クラミジアトラコマチス抗体の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・クラミジアトラコマチス抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオテクノロジー、研究機関、その他） ・クラミジアトラコマチス抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・クラミジアトラコマチス抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Chlamydia Trachomatis Antibodies will have significant change from previous year. By the most conservative estimates of global Chlamydia Trachomatis Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Chlamydia Trachomatis Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Chlamydia Trachomatis Antibodies market by product type,...
  • 世界の連鎖状球菌グループB抗体市場予測 2021年-2026年
    LPI21MY9663 / LP Information / 2021年5月 / LPインフォメーション社の「連鎖状球菌グループB抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単クローン、多クローンなど、用途別には、病院・診断研究所、製薬・バイオ技術、研究所、その他などにセグメント区分してまとめました。連鎖状球菌グループB抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・連鎖状球菌グループB抗体の世界市場概要（サマリー） ・連鎖状球菌グループB抗体の企業別販売量・売上 ・連鎖状球菌グループB抗体の企業別市場シェア ・連鎖状球菌グループB抗体の世界市場規模 2016年-2021年：種類別（単クローン、多クローン） ・連鎖状球菌グループB抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオ技術、研究所、その他） ・連鎖状球菌グループB抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・連鎖状球菌グループB抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Streptococcus Group B Antibodies will have significant change from previous year. By the most conservative estimates of global Streptococcus Group B Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Streptococcus Group B Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Group B Antibodies...
  • 世界の結核菌抗体市場予測 2021年-2026年
    LPI21MY9597 / LP Information / 2021年5月 / LPインフォメーション社の「結核菌抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、モノクローナル、ポリクローナルなど、用途別には、病院・診断研究所、製薬・バイオテクノロジー、研究所、その他などにセグメント区分してまとめました。結核菌抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・結核菌抗体の世界市場概要（サマリー） ・結核菌抗体の企業別販売量・売上 ・結核菌抗体の企業別市場シェア ・結核菌抗体の世界市場規模 2016年-2021年：種類別（モノクローナル、ポリクローナル） ・結核菌抗体の世界市場規模 2016年-2021年：用途別（病院・診断研究所、製薬・バイオテクノロジー、研究所、その他） ・結核菌抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・結核菌抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Mycobacterium Tuberculosis Antibodies will have significant change from previous year. By the most conservative estimates of global Mycobacterium Tuberculosis Antibodies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Mycobacterium Tuberculosis Antibodies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Mycobacterium Tuberculosis Antibodies market by product type,...
  • 世界の組換え抗体（rAbs）市場予測 2021年-2026年
    LPI21MY9565 / LP Information / 2021年5月 / LPインフォメーション社の「組換え抗体（rAbs）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、うさぎ、ねずみ、やぎ、その他など、用途別には、病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他などにセグメント区分してまとめました。組換え抗体（rAbs）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・組換え抗体（rAbs）の世界市場概要（サマリー） ・組換え抗体（rAbs）の企業別販売量・売上 ・組換え抗体（rAbs）の企業別市場シェア ・組換え抗体（rAbs）の世界市場規模 2016年-2021年：種類別（うさぎ、ねずみ、やぎ、その他） ・組換え抗体（rAbs）の世界市場規模 2016年-2021年：用途別（病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他） ・組換え抗体（rAbs）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・組換え抗体（rAbs）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Recombinant Antibodies (rAbs) will have significant change from previous year. By the most conservative estimates of global Recombinant Antibodies (rAbs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Recombinant Antibodies (rAbs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Antibodies (rAbs) market by product type,...
  • 世界の大腸菌抗体市場予測 2021年-2026年
    LPI21MY9522 / LP Information / 2021年5月 / LPインフォメーション社の「大腸菌抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、大腸菌（E. coli）抗体、E. coliO157抗体など、用途別には、大学、病院、政府研究機関、製薬会社などにセグメント区分してまとめました。大腸菌抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・大腸菌抗体の世界市場概要（サマリー） ・大腸菌抗体の企業別販売量・売上 ・大腸菌抗体の企業別市場シェア ・大腸菌抗体の世界市場規模 2016年-2021年：種類別（大腸菌（E. coli）抗体、E. coliO157抗体）...According to this latest study, the 2021 growth of Escherichia Coli Antibody will have significant change from previous year. By the most conservative estimates of global Escherichia Coli Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Escherichia Coli Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Escherichia Coli Antibody market by product type,...
  • 世界のウサギ用ELISAキット市場予測 2021年-2026年
    LPI21MY9015 / LP Information / 2021年5月 / LPインフォメーション社の「ウサギ用ELISAキットの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、非抱合型、アルカリホスファターゼ、ビオチン、その他など、用途別には、病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他などにセグメント区分してまとめました。ウサギ用ELISAキットのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ウサギ用ELISAキットの世界市場概要（サマリー） ・ウサギ用ELISAキットの企業別販売量・売上 ・ウサギ用ELISAキットの企業別市場シェア ・ウサギ用ELISAキットの世界市場規模 2016年-2021年：種類別（非抱合型、アルカリホスファターゼ、ビオチン、その他） ・ウサギ用ELISAキットの世界市場規模 2016年-2021年：用途別（病院＆診断研究所、製薬＆バイオテクノロジー、研究機関、その他） ・ウサギ用ELISAキットの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ウサギ用ELISAキットのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Rabbit ELISA Kits will have significant change from previous year. By the most conservative estimates of global Rabbit ELISA Kits market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rabbit ELISA Kits market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Rabbit ELISA Kits market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆